KALV

KalVista Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$19.90

Market Cap

$1.02B

Beta

-0.29

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+13.98%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-8.04%

Debt / Equity0.00

Interest Coverage-8.7x

No credit card required

Already have an account? Sign in to view the full analysis for KALV.